For instance, EVs isolated from genetically modified cells overexpressing CD47 hybridized with thermosensitive liposomes loaded with a photothermal agent and an immune adjuvant have been used as a combined photothermal therapy and cancer immunotherapy [46]. This evidence concerns the gene CD47 and cancer.